Information and Risk Modification Trial (INFORM): Design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Silarova, Barbora ^a   Lucas, Joanne ^b   Butterworth, Adam S ^b   Di Angelantonio, Emanuele ^b   Girling, Christine ^c   Lawrence, Kathryn ^c   Mackintosh, Stuart ^b   Moore, Carmel ^b   Payne, Rupert A ^d   Sharp, Stephen J ^a   Shefer, Guy ^a   Tolkien, Zoe ^b   Usher Smith, Juliet ^b   Walker, Matthew ^b   Danesh, John ^b   Griffin, Simon ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Patient and Public Involvement Representatives   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Behaviour; Cardiovascular diseases; Communication; Genetic; Phenotypic; Physical activity; Protocol; Randomised controlled trial; Risk

Indexed keywords

ADULT; CARDIOVASCULAR DISEASES; CONTROLLED STUDY; ENGLAND; FEMALE; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; INFORMATION PROCESSING; LIFESTYLE; MALE; METHODOLOGY; MIDDLE AGED; PRIMARY PREVENTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; ENGLAND; FEMALE; FOCUS GROUPS; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PRIMARY PREVENTION; RESEARCH DESIGN; RISK FACTORS;

EID: 84940846136     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-2192-5     Document Type: Article

References (72)

1. World Health Organization. Global status report on noncommunicable diseases 2010. 2011. http://whqlibdoc.who.int/publications/2011/9789240686458-eng.pdf?ua=1. Accessed 5 May 2014.
2. Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. World Health Organization. 2011. http://whqlibdoc.who.int/publications/2011/9789241564373-eng.pdf. Accessed 5 May 2014.
3. World Health Organization. The top 10 causes of death 2013 Fact sheet no. 310. 2013. http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed 25 April 2014.
4. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11), e442.
5. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1 Pt 2):293-8.
6. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335(7611):136.
7. Woodward M, Brindel P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93(2):172-6.
8. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987-1003.
9. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611-9.
10. JBS3 Board. Joint British Societies 'consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100 Suppl 2:ii1-ii67.
11. Goff Jr DC, Lloyd-Jones DM, Bennett G, O'Donnell CJ, Coady S, Robinson J, et al. ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S49-73.
12. NHS Employers and British Medical Association Quality and Outcomes Framework Guidance for GMS Contract 2011-12. London: The NHS Confederation (Employers) Company; 2011.
13. Krogsbøll LT, Jørgensen KJ, Larsen CG, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis. BMJ. 2012;345, e7191.
14. Satish M. Coronary heart disease in clinical practice. London: Goldaming, Springer; 2005.
15. Gaziano M, Ridker PM, Libby P. Primary and secondary prevention of coronary heart disease. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Braunwald's heart disease. A textbook of cardiovascular medicine. Philadelphia: Elsevier Saunders; 2012. p. 1010-35.
16. Rabar S, Harker M, O'Flynn N, Wierzbicki AS, Guideline Development Group. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ. 2014;349:g4356.
17. National Institute for Health and Care Excellence. Prevention of cardiovascular disease (PH25) - review proposal. Centre for Public Health Excellence. 2010. http://www.nice.org.uk/guidance/ph25/documents/prevention-of-cardiovascular-disease-review-decision2. Accessed 25 April 2014.
18. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart. 2006;92(12):1752-9.
19. Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med. 2010;170(3):230-9.
20. Wang C, Bowen DJ, Kardia SL. Research and practice opportunities at the intersection of health education, health behaviour and genomics. Health Educ Behav. 2005;32(5):686-701.
21. Institute of Medicine. Initial National priorities for Comparative Effectiveness research. Washington, DC: Institute of Medicine; 2009.
22. Rosenstock IM. Adoption and maintenance of lifestyle modifications. Am J Prev Med. 1988;4(6):349-52.
23. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev. 2010;2010(10):CD007275.
24. Moore C, Sambrook J, Walker M, Tolkien Z, Kaptoge S, Allen D, et al. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials. 2014;15:363.
25. NHS Blood and Transplant criteria for giving blood, http://www.blood.co.uk/giving-blood/who-can-give-blood/. Accessed 25 April 2014.
26. INFORM Study. http://www.informstudy.org.uk/index.htm. Accessed 20 April 2015.
27. Persell SD, Lloyd-Jones DM, Friesema EM, Cooper AJ, Baker DW. Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. J Gen Intern Med. 2013;28(4):554-60.
28. Payne RA. Cardiovascular risk. Br J Clin Pharmacol. 2012;74(3):396-410.
29. D'Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-53.
30. Soureti A, Hurling R, Murray P, van Mechelen W, Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. Eur J Cardiovasc Prev Rehabil. 2010;17(5):519-23.
31. Carlsson AC, Wandell PE, Gigante B, Leander K, Hellenius ML, de Faire U. Seven modifiable lifestyle factors predict reduced risk for ischemic cardiovascular disease and all-cause mortality regardless of body mass index: A cohort study. Int J Cardiol. 2013;168(2):946-52.
32. Akesson A, Weismayer C, Newby PK, Wolk A. A combined effect of low-risk dietary and lifestyle behaviours in primary prevention of myocardial infarction in women. Arch Intern Med. 2007;167(19):2122-7.
33. Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008;5(1), e12.
34. NHS choices. 5 A DAY. http://www.nhs.uk/LiveWell/5ADAY/Pages/5ADAYhome.aspx. Accessed 25 April 2014.
35. SACN Advice on Fish Consumption. 2004. https://www.gov.uk/government/publications/sacn-advice-on-fish-consumption. Accessed 25 April 2014.
36. World Cancer research Fund. Red and processed meat and cancer prevention. http://www.wcrf-uk.org/uk/preventing-cancer/ways-reduce-cancer-risk/red-and-processed-meat-and-cancer-prevention. Accessed 25 April 2014.
37. Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer. 1999;80 Suppl 1:95-103.
38. CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25-33.
39. EPIC-CVD. Individualised CVD risk assessment across Europe. http://www.epiccvd.eu/. Accessed 25 April 2014.
40. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333-8.
41. Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet. 2011;43(4):339-44.
42. IBC 50K CAD Consortium. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet. 2011;7(9):e1002260.
43. Fair AK, Murray PG, Thomas A, Cobain MR. Using hypothetical data to assess the effect of numerical format and context on perception of coronary heart disease risk. Am J Health Promot. 2008;22(4):291-6.
44. Lipkus IM, Samsa G, Rimer BK. General performance on a numeracy scale among highly educated samples. Med Decis Making. 2001;21(1):37-44.
45. Kirby M, Machen L. Impact on clinical practice of the Joint British Societies' cardiovascular risk assessment tools. Int J Clin Pract. 2009;63(12):1683-92.
46. Lopez-Gonzalez AA, Aguilo A, Frontera M, Bennasar-Veny M, Campos I, Vicente-Herrero T, et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. Eur J Prev Cardiol. 2015;22(3):389-96.
47. Hill S, Spink J, Cadilhac D, Edwards A, Kaufman C, Rogers S, et al. Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study. BMC Public Health. 2010;10:108.
48. Knowles JW, Assimes TL, Kiernan M, Pavlovic A, Goldstein BA, Yank V, et al. Randomized trial of personal genomics for preventive cardiology: design and challenges. Circ Cardiovasc Genet. 2012;5(3):368-76.
49. Sheridan SL, Behrend L, Vu MB, Meier A, Griffith JM, Pignone MP. Individuals' responses to global CHD risk: a focus group study. Patient Educ Couns. 2009;76(2):233-9.
50. Sheridan SL, Draeger LB, Pignone MP, Sloane PD, Samuel-Hodge C, Finkelstein EA, et al. Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for Heart to health study. Contemp Clin Trials. 2013;36(2):394-405.
51. Sheridan SL, Draeger LB, Pignone MP, Keyserling TC, Simpson Jr RJ, Rimer B, et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Serv Res. 2011;11:331.
52. Trost SG, O' Neil M. Clinical use of objective measures of physical activity. Br J Sports Med. 2014;48(3):178-81.
53. Rock CL, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Newman VA, et al. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005;23(27):6631-8.
54. Price CH, Tucker L, Griffin SJ, Holman RR. The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovasc Diabetol. 2008;7:21.
55. Ekelund U, Griffin SJ, Wareham NJ. Physical activity and metabolic risk in individuals with a family history of type 2 diabetes. Diabetes Care. 2007;30(2):337-42.
56. Godino JG, van Sluijs EMF, Marteau TM, Sutton S, Sharp SJ, Griffin SJ. Effect of communicating genetic and phenotypic risk for type 2 diabetes in combination with lifestyle advice on objectively measured physical activity: protocol of a randomised controlled trial. BMC Public Health. 2012;12:444.
57. Middlemass JB, Yazdani MF, Kai J, Standen PJ, Qureshi N. Introducing genetic testing for cardiovascular disease in primary care: a qualitative study. Br J Gen Pract. 2014;64(622):e282-9.
58. Meyer SB, Coveney J, Ward PR. A qualitative study of CVD management and dietary changes: problems of 'too much' and 'contradictory' information. BMC Fam Pract. 2014;15:25.
59. White IR, Thompson SG. Adjusting for partially missing baseline measurements in randomized trials. Stat Med. 2005;24(7):993-1007.
60. Wareham NJ, Jakes RW, Rennie KL, Jo M, Hennings S, Day NE. Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol. 2002;1:168-74.
61. Knapp M, Beecham J. Reduced list costings: examination of an informed short cut in mental health research. Health Econ. 1993;4:313-22.
62. Diefenbach MA, Weinstein ND, O'Reilly J. Scales for assessing perceptions of health hazard susceptibility. Health Educ Res. 1983;8:181-92.
63. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener. Med Care. 2003;41:1284-94.
64. Watson M, Lloyd S, Davidson J, Meyer L, Ebbs S, Murday V. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer. 1999;79:868-74.
65. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997;127:96-972.
66. Ware JE, Kosinski M, Keller SK. SF-36® Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute; 1994.
67. Ajzen I. Constructing a TpB Questionnaire: Conceptual and Methodological Considerations. 2002. http://www.uni-bielefeld.de/ikg/zick/ajzen%20construction%20a%20tpb%20questionnaire.pdf. Accessed 25 April 2014.
68. Broadbent E, Petrie KJ, Main J, Weinman J. The Brief Illness Perception Questionnaire. J Psychosom Res. 2006;60(6):631-7.
69. Sanderson SC, Persky S, Michie S. Psychological and behavioral responses to genetic test results indicating increased risk of obesity: Does the causal pathway from gene to obesity matter? Public Health Genomics. 2010;13(1):34-47.
70. Zimet G, Dahlem N, Zimet S, Farley G. The Multidimensional Scale of Perceived Social Support. J Pers Assess. 1988;52:30-41.
71. Peretti-Watel P, L'Haridon O, Seror V. Time preferences, socioeconomic status and smokers' behaviour, attitudes and risk awareness. Eur J Public Health. 2013;23(5):783-8.
72. Lundberg O, Nyström Peck M. A simplified way of measuring sense of coherence: experiences from a population survey in Sweden. Eur J Public Health. 1995;5:56-9.